PMV Pharmaceuticals PMVP
NASDAQ PMVP
$1.26 +0.04 (+3.28%)
At close: Nov 11, 2026 · 4:00 PM EST

PMV Pharmaceuticals (PMVP) Other Accumulated Expenses (2019 - 2026)

Updated

PMV Pharmaceuticals (PMVP) posted Other Accumulated Expenses of $3.2 million for Q2 2026, up 4.8% from $3.06 million a year earlier and up 32.6% from the prior quarter.

Analysis

PMV Pharmaceuticals (PMVP) Other Accumulated Expenses (2019 - 2026) Analysis & Trends

At the end of FY2025, PMV Pharmaceuticals' Other Accumulated Expenses came in at $4.53 million, down 9.5% from FY2024.

  • Annual Other Accumulated Expenses shows a five-year compound annual growth rate of 7.8% (FY2020 to FY2025).
  • In prior years, PMV Pharmaceuticals' Other Accumulated Expenses was $5.01 million in FY2024 (+11.3%), $4.5 million in FY2023 (+55.3%), $2.9 million in FY2022 (-23.7%) and $3.8 million in FY2021 (+22.1%).
  • Quarterly Other Accumulated Expenses has run from a low of $1.76 million in Q1 2022 to a high of $5.01 million in Q4 2024 over five years.
  • On a year-over-year basis, Other Accumulated Expenses increased in five of the last eight quarters, with growth averaging 3.1%.
  • The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q4 2023, with growth of 55.3%; the weakest was Q4 2022, with a decline of 23.7%.
  • According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $2.42 million (Q1 2026), $4.53 million (Q4 2025) and $3.92 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 PMV Pharmaceuticals 80.80 Mn -307.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 138,000.00
Jun 30, 2026 3.20 Mn
Mar 31, 2026 2.42 Mn
Dec 31, 2025 4.53 Mn
Sep 30, 2025 3.92 Mn
Jun 30, 2025 3.06 Mn
Mar 31, 2025 2.78 Mn
Dec 31, 2024 5.01 Mn
Sep 30, 2024 4.00 Mn
Jun 30, 2024 3.00 Mn
Mar 31, 2024 2.22 Mn
Dec 31, 2023 4.50 Mn
Sep 30, 2023 3.77 Mn
Jun 30, 2023 2.72 Mn
Mar 31, 2023 1.85 Mn
Dec 31, 2022 2.90 Mn
Sep 30, 2022 2.96 Mn
Jun 30, 2022 2.51 Mn
Mar 31, 2022 1.76 Mn
Dec 31, 2021 3.80 Mn
API Access

PMV Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=PMVP&period=max&api_key=YOUR_API_KEY